ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall K. Fields sold 2,000 shares of ReposiTrak stock in a transaction on Tuesday, June 24th. The stock was sold at an average price of $19.44, for a total value of $38,880.00. Following the sale, the chief executive officer now directly owns 165,000 shares of the company's stock, valued at approximately $3,207,600. This trade represents a 1.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
ReposiTrak Stock Performance
Shares of NYSE:TRAK traded down $0.40 during mid-day trading on Wednesday, reaching $19.04. The stock had a trading volume of 58,618 shares, compared to its average volume of 43,838. ReposiTrak Inc. has a twelve month low of $14.23 and a twelve month high of $25.01. The company has a market capitalization of $348.05 million, a price-to-earnings ratio of 57.18 and a beta of 0.54. The company has a debt-to-equity ratio of 0.01, a current ratio of 6.03 and a quick ratio of 6.03.
ReposiTrak Cuts Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, August 14th. Stockholders of record on Monday, June 30th will be issued a $0.0182 dividend. This represents a $0.07 annualized dividend and a dividend yield of 0.38%. The ex-dividend date of this dividend is Monday, June 30th. ReposiTrak's dividend payout ratio (DPR) is 20.59%.
Institutional Trading of ReposiTrak
An institutional investor recently raised its position in ReposiTrak stock. Ellsworth Advisors LLC raised its holdings in ReposiTrak Inc. (NYSE:TRAK - Free Report) by 10.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 31,289 shares of the company's stock after acquiring an additional 2,997 shares during the period. Ellsworth Advisors LLC owned about 0.17% of ReposiTrak worth $634,000 as of its most recent filing with the Securities and Exchange Commission. 27.35% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, Wall Street Zen upgraded ReposiTrak from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd.
Read Our Latest Stock Analysis on TRAK
About ReposiTrak
(
Get Free Report)
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ReposiTrak, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.
While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
